Secretory component of epithelial cells is a surface receptor for polymeric immunoglobulins by unknown
Brief Definitive Report 
SECRETORY  COMPONENT  ON  EPITHELIAL  CELLS  IS  A 
SURFACE  RECEPTOR  FOR  POLYMERIC  IMMUNOGLOBULINS* 
B~  SYLVIA  S.  CRAGO,  ROSE  KULHAVY,  SHIRLEY  J.  PRINCE,  AND JIRI MESTECKY 
(From the Department of Microbiology,  The Institute of Dental Research and the Comprehensive 
Cancer Center, The University of Alabama, Birmingham, Alabama 35294) 
The transport  of immunoglobulins  across mucous membranes is a  selective 
process that  involves different classes of immunoglobulins  in different species 
(1).  In human  external  secretions,  the  principal  immunoglobulin  is secretory 
IgA (s-IgA). This molecule is the product of plasma cells that secrete polymeric 
IgA with J  chain,  and of epithelial  cells that  synthesize secretory component 
(SC). The SC becomes linked to the IgA during transport through the epithelial 
cells  (2).  In  some cases of IgA deficiency,  secretory IgM  (s-IgM)  rather  than 
s-IgA appears in external  secretions  (2,  3).  Several models of active transport 
proposed  to  explain  the  selective  appearance  of IgA  and  IgM  in  secretions 
suggest that initially these immunoglobulins are selectively bound to a receptor 
on the  surface of exocrine epithelial  cells  (2,  4).  The possibility that  SC may 
serve  as  an  immunoglobulin  receptor  on  epithelial  cells  is  implied  by  the 
following findings: J chain-containing polymeric IgA and IgM molecules exhibit 
an  in vitro  affinity for SC  (2); the infusion of an  animal  with anti-SC  serum 
lowers the ratio of intestinal  s-IgA to serum IgA (5); and immunofluorescence 
studies on tissue sections of the intestine reveal the coincidental appearance of 
SC and IgA on the basal and lateral surfaces of epithelial cells (2). 
The present  studies were undertaken  to determine  whether  SC is indeed a 
receptor  for  immunoglobulins  of various  classes,  subclasses,  and  molecular 
configurations.  The human epithelial cell line HT-29, which displays SC on the 
cell surface (6), and sections of human fetal intestines were examined for their 
ability  to  bind  various  immunoglobulins  on  the  cell  membrane  or  in  the 
cytoplasm. 
Materials  and Methods 
Preparation of Immunoglobulins  and  SC.  Secretory IgA from colostrum,  and polymeric or 
monomeric IgA from sera of patients with IgA myelomatosis, and IgG from normal human serum 
were purified by ammonium sulfate precipitation, followed by molecular sieve chromatography 
on Sephadex G-200 and Sepharose 6B, and DEAE-cellulose chromatography as described in detail 
(7).  IgM proteins were purified from sera of patients with Waldenstr6m's macroglobulinemia by 
euglobulin precipitation with a  15-fold excess of cold distilled water and subsequent Sephadex 
G-200 gel filtration (8). SC was purified by the method of Brandtzaeg (9) from colostrum and milk 
of normal mothers and a patient with panhypogammaglobulinemia. The purity of these prepara- 
tions was  determined by  immunoelectrophoresis and  double  immunodiffusion with  polyvalent 
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antisera to human  serum and colostrum  (Behring Diagnostics, American Hoechst Corp.,  Som- 
merville, N.J.). 
Reagents.  Monovalent antisera  (specific for the heavy (H) chains of IgA, IgM, or IgG) were 
prepared in this laboratory as previously described (7), or were obtained from a commercial source 
(Behring Diagnostics). Anti-SC reagents were prepared by adsorption of anti-s-IgA antisera with 
purified serum IgA (10) or by immunization of rabbits and goats with SC that was purified as 
described  above;  a  commercially  available  rabbit  anti-human  SC  was  also  used  (Behring 
Diagnostics).  Preparations of anti-J chain and anti-lactoferrin reagents have been described (7, 
11).  Procedures  used for the preparation  and fluorochrome labeling of T-globulin fractions and 
F(ab')2 fragments of anti-SC and anti-H chain reagents have been described (12). 
Tissue and Cell Processing.  Tissue from the small intestine was obtained from human fetuses 
(age determined  by crown to rump measurements).  Tissues were either immediately frozen in 
liquid nitrogen or were fixed in cold 95%  ethanol  and embedded in paraffin  by the  method  of 
Sainte-Marie  (13); frozen sections  (4/~m)  were fixed in 96  ml of 95% ethanol  +  5 ml of glacial 
acetic  acid.  The  presence  of SC  was  determined  by  incubation  with  tetramethylrhodamine- 
isothiocyanate  (TRITC) labeled anti-SC.  To determine the binding of immunoglobulins,  tissue 
sections were  incubated  with  TRITC-laboled monomeric or polymeric myeloma IgA,  colostral 
IgA, macroglobulin IgM, or IgG. 
A line of human epithelial cells, HT-29 (developed at the Sloan-Kettering Institute for Cancer 
Research,  New  York)  was  propagated  in  tissue  culture  and  allowed  to  grow  in  monolayers, 
according to the technique of Huang et al.  (6).  In some experiments, cells were recovered from 
monolayers by a 5-rain treatment at 37"C with 0.25% trypsin and 10 -2 M EDTA, washed, and then 
allowed to adhere to sterile glass cover slips for 48-72 h before examination. In other experiments, 
cells were scraped off the flask wall, washed, and resuspended in phosphate-buffered saline (PBS) 
+  1% bovine serum albumin  +  0.3%  sodium  azide for immediate examination.  Cultures  were 
maintained in McCoy's Modified 5A medium (Grand Island Biological Co., Grand Island,  N. Y.) 
that  contained  15%  fetal  bovine serum  (Reheis  Chemical  Co.,  Kankakee,  Ill.),  penicillin and 
streptomycin, and L-glutamine. All cultures were incubated at 37°C in 5% CO2. 
The  presence  of SC  on  the  cell  membrane  was  determined  with  the  fluorochrome-labeled 
F(ab')2 fragment of anti-SC reagents.  Binding affinities were determined by incubation of cells 
with various immunoglobulin preparations (50 ftl of a solution containing 4 mg/ml) for 45 rain at 
room temperature.  Cells were washed in PBS and then incubated with fluorochrome-labeled anti- 
H chain reagents or their F(ab')s fragments. 
Cell  suspensions  were  prepared  as  described  by  Winchester  (12),  and  all  specimens  were 
examined with a  Leitz Orthoplan  (Leitz,  Wetzlar,  Germany)  fluorescence microscope equipped 
with epi-illumination. 
Results 
Immunoglobulin Binding by Intestinal Tissues.  Sections of human  small 
intestine obtained from fetuses at 8, 10, 11, 12, 131/2, 14, and 16 wk of gestation 
were  examined  by  direct  immunofluorescence  for  the  presence  of  SC  and 
endogenous immunoglobulins.  Intestinal tissue sections incubated with labeled 
anti-H chain reagents alone exhibited no cellular fluorescence, which indicated 
that  endogenous  immunoglobulins  were absent.  SC  was not detected in fetal 
tissues until the 16th-wk of gestation. These findings match those of Ogra et al. 
(14) as to the time of appearance  of SC in human  fetal development.  At this 
stage,  the  epithelial  cells  fluoresced  on  staining  with  fluorochrome-labeled 
polymeric IgA (Fig. la), whereas epithelial cells of tissue sections from younger 
fetuses  (which  displayed  no  SC)  did  not  exhibit  immunoglobulin  binding. 
Specificity of the  immunoglobulin  binding  (at  16 wk)  was  confirmed  by the 
absence  of fluorescence  when  the  cells  were  pre-incubated  with  unlabeled 
polymeric IgA. TRITC-labeled monomeric IgA and serum IgG did not bind to the 
cytoplasm of epithelial cells from fetuses of any age. The fluorescence observed 
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FIG.  la.  Binding  of RITC-labeled  polymeric  IgA  to the  cytoplasm  of fetal intestinal 
epithelium  at 16 wk  of gestation; b. Expression  of SC  on the  surface  of HT-29  colon 
carcinoma cells  as disclosed by RITC-labeled anti-SC reagent; c. Binding of  polymeric IgA 
to the surface of  HT-29 cells;  d. Binding of  IgM to the surface of  HT-29 cells. 
meric IgA; fluorescence of marginal  intensity was observed with TRITC-labeled 
s-IgA. 
Binding of Immunoglobulins  to the Surface of Colonic Carcinoma Cells.  HT- 
29 cells attached to a  cover slip or in single cell suspensions were examined for 
the presence of SC on the membrane and for their ability to bind immunoglob- 
ulins  of various  classes,  subclasses,  and  molecular  configurations.  SC  was 
expressed most prominently  after 72 h  of cultivation;  at  that  time 35% of the 
cells fluoresced with labeled anti-SC reagents (Fig. lb). Incubation of these cells 
with polymeric IgA  myeloma proteins  and  subsequent  addition  of fluorescein 
isothiocyanate-labeled alpha  chain  specific antisera  revealed  immunoglobulin 
binding  to  the  cell  surface.  Both  IgA1  and  IgA2  subclasses  with  kappa  and 
lambda chains were included in these IgA myeloma proteins.  Characteristics of 
these immunoglobulins and their capacities for binding to HT-29 cells are given 
in Table I and Fig.  lc.  Binding of immunoglobulins to epithelial cells was not 
affected by IgA subclass or light (L) chain type, but was dependent on molecular 
configuration,  as shown by the failure of monomeric IgA and s-IgA to bind to 
HT-29 cells. Three of four IgM proteins also bound to the surface of HT-29 cells. 
The properties of the immunoglobulins are indicated in Table I and Fig. ld. IgG 
or labeled anti-H chain reagents did not react with the cells. 
The binding of polymeric IgA and IgM to the surface of epithelial cells could 
be blocked by incubating the cells with anti-SC before addingimmunoglobulins; CRAGO  ET  AL.  BRIEF  DEFINITIVE  REPORT 
TABLE  I 
Binding of lmmunoglobulins  by HT-29 Epithelial  Cells 
Class  Configuration*  J Chains  L Chain  Binding 
IgA2 
IgA1 
IgA1 
IgA1 
i-lgA 
IgM 
IgM 
IgM 
IgM 
IgG 
Polymenc 
Polymerlc 
Monomeric 
Monomeric 
Polymeric 
Polymeric 
Polymeric 
Polymeric 
Polymeric 
Monomer 
+  k  + 
÷  K  ÷ 
g 
K 
+  Kandk 
÷  K  + 
+  k  + 
+  K  -- 
÷  K  ÷ 
--  Kandk  - 
* Configuration  determined  by polyacylamide  gel electrophoresis  and ultracentrifugation  (26). 
S Presence  of J  chain determined  by polyacylamide  gel electrophoreeis  and immunoelectropho- 
resis (26). 
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anti-lactoferrin  or anti-J chain reagents had no blocking effect. 
HT-29  cells  treated  with  trypsin  lost  their  membrane-associated  SC  as 
evidenced by their failure to react with fluorochrome-labeled anti-SC; these SC- 
negative  cells  did  not bind  monomeric  or polymeric  immunoblobulins  of any 
cIass. However, when these treated HT-29 cells were cultivated for at least 24 h, 
surface  SC  reappeared  and  the  binding  of polymeric  immunoglobulins  was 
restored. 
Discussion 
SC  is a  glycoprotein  constituting  an integral  part of the  s-IgA molecule.  A 
number of conjectures have been put forth to account for its function.  Within 
the s-IgA molecule, SC affords protection against attack by proteolytic enzymes 
(15) and contributes to the stabilization of the quaternary structure of s-IgA (4, 
16,  17).  South  et  al.  (18)  suggested  that  SC  might  be  instrumental  in  the 
transport of IgA from serum into external secretions.  However, the parenteral 
infusion of large  amounts of serum  IgA did  not increase  the  levels  of IgA in 
secretions  because  serum-derived  7S  IgA  is  not  transported  into  external 
secretions (4).  Subsequent investigations revealed that only polymeric, J chain- 
containing IgA and IgM were transported into exocrine fluids (2, 4). 
It has also been postulated that SC might be involved in the homing of IgA 
precursor  cells  to  secretory  tissues.  This  possibility  was  prompted  by  the 
absence of IgA-containing cells from the submucosal lymphoid tissues of an SC 
deficient patient (19).  However, the failure to reveal SC receptors on the surface 
of normal or stimulated peripheral  blood lymphocytes  (20,  21) did not support 
this contention. 
Earlier  investigations  strongly  implied  that  SC  mediates  the  transport  of 
polymeric  immunoglobulins  (2,  4,  5),  and  proposed that  SC  acts  as a  specific 
receptor (2).  However, evidence has not been offered for the binding of polymeric 
immunoglobulins to membrane-associated SC on living epithelial cells.  Results 
of the present  study validate  the concept that  SC  does indeed  function as an 
immunoglobulin receptor.  We have demonstrated that the binding of polymeric 
immunoglobulins  to  the  surface  or cytoplasm  of epithelial  cells  requires  the 
presence  of SC  and  is  inhibited  by  anti-SC.  We  have  also  shown  that  only 
polymeric immunoglobulins devoid of SC will bind to intestinal epithelial  cells 1836  CRAGO  ET  AL.  BRIEF  DEFINITIVE  REPORT 
and will do so irrespectively of IgA subclass and L-chain type. The participation 
of J  chain in the process of SC binding of polymeric immunoglobulins remains 
unresolved (2, 22). 
This study concerns only the initial event in the transport of immunoglobulins 
through the epithelial cells.  Reports of IgA associated with SC  in cytoplasmic 
vesicles  within  epithelial  cells  (23-25)  suggest  that  membrane-bound  IgA  is 
then internalized and transported to the secretory surface of the exocrine cell. 
Summary 
Epithelial cells of human fetal intestines and of a colonic carcinoma cell line 
(HT-29) exhibited intracellular and surface binding of polymeric immunoglobu- 
lins of IgA and IgM classes; monomeric IgA and IgG did not bind to these cells. 
Secretory component was  identified  as  the  receptor involved in  the  immuno- 
globulin binding.  This conclusion was confirmed by the following experiments: 
trypsin abrogated the surface binding of polymeric immunoglobulin, reappear- 
ance of surface secretory component (SC) restored immunoglobulin binding; the 
appearance of SC  in developing fetal tissues  coincided with their potential to 
bind  polymeric  immunoglobulin;  anti-SC  reagents  inhibited  the  binding  of 
immunoglobulins  to epithelial  cells;  and  SC-containing  secretory IgA did not 
bind to the surface of HT-29 cells. 
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